During the past decade, Hospital del Mar conducted 429 clinical trials. In the 10-year time frame, 429 clinical trials started and 143 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 212 clinical trials started and 96 clinical trials were completed. i.e. 45.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital del Mar" #1 sponsor was "Parc de Salut Mar" with 39 trials, followed by "Pfizer" with 32 trials sponsored, "PETHEMA Foundation" with 24 trials sponsored, "Spanish Breast Cancer Research Group" with 21 trials sponsored and "Celgene" with 21 trials sponsored. Other sponsors include 514 different institutions and companies that sponsored additional 266 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital del Mar" #1 collaborator was "Hospital del Mar" with 17 trials as a collaborator, "Pfizer" with 16 trials as a collaborator, "Hoffmann-La Roche" with 12 trials as a collaborator, "Instituto de Salud Carlos III" with 12 trials as a collaborator and "Germans Trias i Pujol Hospital" with 10 trials as a collaborator. Other collaborators include 488 different institutions and companies that were collaborators in the rest 333 trials.

According to Clinical.Site data, the most researched conditions in "Hospital del Mar" are "Breast Cancer" (26 trials), "Coronary Artery Disease" (16 trials), "Multiple Myeloma" (13 trials), "HIV Infections" (12 trials) and "Atrial Fibrillation" (11 trials). Many other conditions were trialed in "Hospital del Mar" in a lesser frequency.

Most popular intervention types in "Hospital del Mar" are "Drug" (455 trials), "Other" (70 trials), "Device" (44 trials), "Procedure" (42 trials) and "Biological" (34 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (118 trials), "Cyclophosphamide" (15 trials), "Carboplatin" (14 trials), "placebo" (14 trials) and "Capecitabine" (12 trials). Other intervention names were less common.

The vast majority of trials in "Hospital del Mar" are 578 trials for "All" genders, 54 trials for "Female" genders and 20 trials for "Male" genders.

Currently, there are 205 active trials in "Hospital del Mar". 3 are not yet recruiting, 122 are recruiting, 76 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 324 completed trials in Hospital del Mar, 2 suspended trials, and 58 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital del Mar, 38 "Phase 1" clinical trials were conducted, 170 "Phase 2" clinical trials and 222 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 69 trials, and there were also 69 trials that are defined as “Not Applicable".